NCT06211868

Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 3,000 (estimated)
• Sponsor: National University Hospital, Singapore · Academic / Other
• Sex: All
• Age: 40 Years – 70 Years
• Healthy volunteers: —

Summary

Project RESET is a Singapore National Medical Research Council Large Collaborative Grant funded program that brings together a nationwide community of cardiovascular, metabolic, and digital health researchers, as well as clinicians across primary and tertiary care to study the immune, lipid and metabolic drivers of early cardiovascular disease. RESET incorporates a nested randomised controlled trials (RCT) to test the use of a combined digital wearable and AI-human symbiotic lifestyle intervention to halt or reverse the progression of early disease.

Conditions

• Cardiovascular Diseases
• Metabolic Syndrome
• Non-Alcoholic Fatty Liver Disease

Interventions

Type	Name	Description
BEHAVIORAL	Digital wearable and AI-human symbiotic lifestyle intervention	Digital wearable and AI-human symbiotic lifestyle intervention

Timeline

• Start date: 2024-03-01
• Primary completion: 2029-09-01
• Completion: 2030-09-01
• First posted: 2024-01-18
• Last updated: 2024-10-15

Locations

1 site across 1 country: Singapore